123 related articles for article (PubMed ID: 37981223)
1. Design of a novel nanoparticle to use X-ray fluorescence of TiO
Noghreiyan AV; Soleymanifard S; Sazgarnia A
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103890. PubMed ID: 37981223
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the emission spectra and cytotoxicity of TiO
Vejdani Noghreiyan A; Sazegar MR; Mousavi Shaegh SA; Sazgarnia A
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101770. PubMed ID: 32311544
[TBL] [Abstract][Full Text] [Related]
3. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
4. Opto-microfluidic assisted synthesis of photo-protoporphyrin (pPP) conjugated to hollow gold-albumin hybrid nanoshells to enhance the efficiency of photodynamic therapy of triple negative breast cancer cells.
Imanparast A; Shaegh SAM; Attaran N; Ameri AR; Sazgarnia A
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103632. PubMed ID: 37236519
[TBL] [Abstract][Full Text] [Related]
5. Access to a novel near-infrared photodynamic therapy through the combined use of 5-aminolevulinic acid and lanthanide nanoparticles.
Shimoyama A; Watase H; Liu Y; Ogura S; Hagiya Y; Takahashi K; Inoue K; Tanaka T; Murayama Y; Otsuji E; Ohkubo A; Yuasa H
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):607-14. PubMed ID: 24284118
[TBL] [Abstract][Full Text] [Related]
6. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
7. Utilizing photosensitizing and radiosensitizing properties of TiO
Bakhshizadeh M; Mohajeri SA; Esmaily H; Aledavood SA; Varshoei Tabrizi F; Seifi M; Hadizadeh F; Sazgarnia A
Photodiagnosis Photodyn Ther; 2019 Mar; 25():472-479. PubMed ID: 30738223
[TBL] [Abstract][Full Text] [Related]
8. PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy.
Dinakaran D; Sengupta J; Pink D; Raturi A; Chen H; Usmani N; Kumar P; Lewis JD; Narain R; Moore RB
Acta Biomater; 2020 Nov; 117():335-348. PubMed ID: 32956872
[TBL] [Abstract][Full Text] [Related]
9. Combining Pr
Mandl GA; Vettier F; Tessitore G; Maurizio SL; Bietar K; Stochaj U; Capobianco JA
ACS Appl Bio Mater; 2023 Jun; 6(6):2370-2383. PubMed ID: 37267436
[TBL] [Abstract][Full Text] [Related]
10. Carbon-Doped TiO
Yang CC; Tsai MH; Li KY; Hou CH; Lin FH
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035468
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study.
Basoglu H; Bilgin MD; Demir MM
Photodiagnosis Photodyn Ther; 2016 Mar; 13():81-90. PubMed ID: 26751701
[TBL] [Abstract][Full Text] [Related]
12. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
13. In-vitro investigation of cold atmospheric plasma induced photodynamic effect by Indocyanine green and Protoporphyrin IX.
Vejdani Noghreiyan A; Imanparast A; Shayesteh Ara E; Soudmand S; Vejdani Noghreiyan V; Sazgarnia A
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101822. PubMed ID: 32428573
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
15. X-ray-induced nanoparticle-based photodynamic therapy of cancer.
Zou X; Yao M; Ma L; Hossu M; Han X; Juzenas P; Chen W
Nanomedicine (Lond); 2014 Oct; 9(15):2339-51. PubMed ID: 24471504
[TBL] [Abstract][Full Text] [Related]
16. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
17. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
18. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
19. The spectroscopy analyses of PpIX by ultrasound irradiation and its sonotoxicity in vitro.
Wang P; Wang X; Zhang K; Gao K; Song M; Liu Q
Ultrasonics; 2013 Jul; 53(5):935-42. PubMed ID: 23415145
[TBL] [Abstract][Full Text] [Related]
20. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
